Recent advances in pediatric HIV

Area of Science:

• Pediatrics
• Infectious Diseases
• Epidemiology

Background:

• Pediatric human immunodeficiency virus (HIV) infection primarily results from mother-to-infant transmission.
• The World Health Organization projects a significant increase in pediatric HIV cases globally.
• HIV transmission can occur in utero or during delivery, influencing disease onset in infants.

Observation:

• Infants infected with HIV during gestation exhibit earlier clinical symptoms compared to those infected during birth.
• Two cases illustrating early-onset and late-onset pediatric HIV disease are presented.
• Antiretroviral therapy, specifically zidovudine (ZDV), has been proven to substantially decrease perinatal HIV transmission.

Findings:

• Zidovudine (ZDV) administration to HIV-positive pregnant women and their newborns significantly reduces perinatal HIV transmission.
• Universal voluntary HIV testing for pregnant women is crucial for implementing effective prevention strategies.
• A successful program for universal voluntary HIV testing in pregnant women has been established at the University of Arkansas for Medical Sciences.

Implications:

• Implementing widespread HIV screening in pregnant populations is essential for preventing pediatric HIV.
• Early detection and intervention through ZDV prophylaxis can mitigate the impact of HIV on children.
• The described program serves as a model for other institutions aiming to reduce mother-to-child HIV transmission.